Clinical Trials
13
Active:2
Completed:7
Trial Phases
3 Phases
Phase 2:1
Phase 4:1
Not Applicable:11
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Not Applicable
11 (84.6%)Phase 2
1 (7.7%)Phase 4
1 (7.7%)Safety and Efficacy of Electronic Stimulation for Circumferential Reduction and Muscle Toning
Not Applicable
Completed
- Conditions
- Fat NecrosisMuscle Stimulation
- First Posted Date
- 2023-12-01
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- LUTRONIC Corporation
- Target Recruit Count
- 45
- Registration Number
- NCT06152900
- Locations
- 🇺🇸
Lutronic US Headquarters, Billerica, Massachusetts, United States
🇺🇸Union Square Dermatology, New York, New York, United States
Safety and Efficacy Evaluation of the Mosaic Ultra Device
Not Applicable
Recruiting
- Conditions
- PhotoagingAcne VulgarisStretch MarkHair LossWrinkleSkin Texture DisorderScar
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- LUTRONIC Corporation
- Target Recruit Count
- 200
- Registration Number
- NCT06117293
- Locations
- 🇺🇸
Advanced Dermatology, Lincolnshire, Illinois, United States
🇺🇸Lutronic, Billerica, Massachusetts, United States
🇺🇸Dermatology & Skin Health, Peabody, Massachusetts, United States
Pilot Evaluation of the Lutronic PicoPlus System for the Treatment of Benign Pigmented Lesions of the Hands
Not Applicable
Active, not recruiting
- Conditions
- Benign Pigmented Lesions
- First Posted Date
- 2019-12-23
- Last Posted Date
- 2019-12-24
- Lead Sponsor
- LUTRONIC Corporation
- Target Recruit Count
- 41
- Registration Number
- NCT04208100
- Locations
- 🇺🇸
William LoVerme, MD, Billerica, Massachusetts, United States
Histologic Evaluation of Tissue Following Lutronic System Exposure
Not Applicable
- Conditions
- Abdominoplasty
- First Posted Date
- 2019-12-20
- Last Posted Date
- 2019-12-20
- Lead Sponsor
- LUTRONIC Corporation
- Target Recruit Count
- 3
- Registration Number
- NCT04207047
- Locations
- 🇺🇸
William LoVerme, MD, Billerica, Massachusetts, United States
Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema
Phase 4
- Conditions
- Diabetic Macular Edema
- First Posted Date
- 2018-11-30
- Last Posted Date
- 2018-11-30
- Lead Sponsor
- LUTRONIC Corporation
- Target Recruit Count
- 12
- Registration Number
- NCT03759860
- Locations
- 🇰🇷
Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- Next
News
No news found